Biomaterial

Zybio has started to involve in biomaterials production due to its dramatic nation-wide expansion in the recent
years. An independentbiomaterial R&D center was founded to the production of a variety of biomaterials such
as antigens and antibody to guarantee as well as controlling the quality of our lineup products.

Zybio has started to involve in biomaterials production due to its dramatic nation-wide expansion in the recent years. An independent biomaterial R&D center was founded to the production of a variety of biomaterials such as antigens and antibody to guarantee as well as controlling the quality of our lineup products.

Our antigens (native or recombinant) and antibodies (monoclonal or polyclonal) are validated for application in most technologies which are currently applied for in-vitro diagnosis clinical diagnostics assays.

-Antisera
  • Antisera
      Antisera   Source   Application  
      ApoA1   Goat   TIA  
      ApoB   Goat   TIA  
      PA   Goat   TIA  
      IgA   Goat   TIA  
      IgG   Goat   TIA  
      IgM   Goat   TIA  
      C3   Goat   TIA  
      C4   Goat   TIA  
      ApoE   Goat   TIA  
      FIB   Goat   TIA  
      CER   Goat   TIA  
      C1Q   Goat   TIA  
      ALB   Goat   TIA  
Contact
  • Chongqing

    TEL0086 (0)23-68690698

    ADDFloor 3, Building J No. 70-1, 70-2 of Keyuan 4th Street Jiulongpo District, Chongqing Municipality 400039, China

  • Shenzhen

    TEL0086(0)755-23217746

    ADDFloor 1301B, Building D Haicheng Road No.201 Caifugang Building,Baoan District, Shenzhen 518102, Guangdong, P.R.China

Zybio Inc. ownership ICP:20006187